Dr Reddys and Fujifilm call off JV for generic drugs in Japan
Fujifilm realigns its long-term growth strategy for the pharma business
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
M&A activity increases significantly in value terms with a focus on core therapy areas
Indian pharma sector witnesses no deals during May 2013
Venus Remedies gets Mexico patent for potentox
Potentox is a novel antibiotic adjuvant entity effective against quinolones and aminoglycoside-resistant gram negative infections
SCDM Asia Conference receives overwhelming response
Event held for the first time in India sees more than 150 participants from seven countries
Learnings from the Ranbaxy saga
Dinesh Thakur's expose on Ranbaxy is not the first in the history of the pharmaceutical industry nor will it be the last
June 16-30, 2013
{source}<div data-configid="5690019/3504587" style="width: 600px; height: 402px;" class="issuuembed"></div><script…
Intas Pharmaceuticals files DRHP for IPO
The IPO will be made through a public issue of equity shares of face value of Rs 10 each
MoHFW to set up four member committee to regulate stem cell and other cell-based therapies
Committee to submit report within next two months of its formation
Merial’s acquisition of animal health division of Dosch Pharmaceuticals closes in India
The acquired business, Sanofi Synthelabo India, will market Dosch’s 86 animal health products and 50 brands for ruminants, poultry…
US FDA approves Xgeva to treat giant cell tumour of the bone
Xgeva is a monoclonal antibody that binds to RANKL, a protein essential for maintenance of healthy bone